Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
KBT & Schematerapi SG AB
AB
Active
Org 5592365679
Valhallavägen 2, 114 23
Stockholm
Tertiary education
·
NACE 8540
Est. 2020 · 6 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Tertiary education
/
KBT & Schematerapi SG AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
1M
1M
1M
0M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 1M (0% vs 2024)
1M
0%
2025
EBITDA
SEK millions
1M
1M
1M
0M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 0M (-100% vs 2023)
0M
-100%
2024
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
742
612
954
890
773
Staff expenses
−33
−37
−8
—
—
EBITDA
−451
359
848
696
581
Depreciation & amort.
−5
−5
−5
−0
−0
EBIT
−456
354
842
696
581
Net financials
22
7
0
—
—
Profit before tax
−440
377
843
696
582
Tax
—
−79
−176
−144
−125
Net profit
−440
297
666
552
457
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
1 311
2 505
2 077
1 637
1 391
Equity
1 090
1 734
1 631
1 160
795
Long-term debt
5
277
112
174
292
Short-term debt
19
302
125
95
96
Total debt
24
579
237
269
388
Financial ratios
5-year trend
EBITDA margin
−60,7 %
This company
15,8 %
Market median
This company
Market median
484% below market
2021
2025
Equity ratio
83,1 %
This company
38,2 %
Market median
This company
Market median
118% above market
2021
2025
Return on equity
−40,3 %
This company
18,4 %
Market median
This company
Market median
319% below market
2021
2025
Net profit margin
−59,2 %
This company
8,1 %
Market median
This company
Market median
831% below market
2021
2025
Asset turnover
0,57×
This company
1,12×
Market median
This company
Market median
49% below market
2021
2025
Debt / equity
0,20×
This company
0,62×
Market median
This company
Market median
68% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on KBT & Schematerapi SG AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
